Cc1cc(Br)c(Cl)cc1NC(=O)CN1C(=O)C2C3CC(c4ccccc4)C(C3)C2C1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?